Serial #86753205
LIVE

Serial Number

86753205

Owner

Biologics Consulting Group, Inc.

Attorney

Nicole J. Harrell

First Use Date

Jan 15, 2016

Filing Date

Sep 10, 2015

Add to watchlist:

No watchlists yet
View on USPTO

Serial #86753205 Trademark

Serial Number: 86753205 • Registration: 5172332

Serial #86753205 is a trademark filed by Biologics Consulting Group, Inc. on September 10, 2015. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Biologics Consulting Group, Inc. (3 trademarks)

Alexandria, VA 22314

Entity Type: 03

Trademark Details

Filing Date

September 10, 2015

Registration Date

March 28, 2017

First Use Anywhere

January 15, 2016

First Use in Commerce

January 15, 2016

Published for Opposition

June 21, 2016

Goods & Services

Regulatory compliance consulting services, namely, reviewing standards and practices to assist clients with compliance with governmental laws, regulations and rules in the fields of medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; providing technical regulatory affair consulting services directed to medical, medical technology, biopharmaceutical, and biotechnology companies in order to assure compliance with food and drug administration's laws and regulations; provision of information online pertaining to regulatory compliance in the fields of medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; and regulatory compliance consulting in the fields of biologics, pharmaceuticals, prescription drugs and medical devices

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting others in preparing and filing applications for new medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology with governmental regulatory bodies around the world; regulatory submission management, namely, providing simultaneous multiple country submissions of applications for the registration and approval of medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; providing information online regarding regulatory submission management; business management consulting, strategic planning and business advisory services provided to medical, medical technology, biopharmaceutical, and biotechnology companies, and government agencies, educational and research institutions, law firms, and investment firms in the fields of biologics, pharmaceuticals and medical devices; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for drug and medical device approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs and medical devices with governmental regulatory bodies; business consulting services in the field of biologics, pharmaceuticals, prescription drugs and medical devices

Consulting services for others in the field of designing pre-clinical and clinical studies and trials for others; product research and development for others in the fields of biologics, pharmaceuticals, prescription drugs and medical devices; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the field of biologics, pharmaceuticals, prescription drugs and medical devices; scientific consulting and research services relating to the field of pharmaceuticals, medical devices, and life sciences, namely, biology, and medicine; consulting services in the fields of biotechnology and pharmaceuticals, namely, design, development, technical verification and technical validation of manufacturing and filling processes, drug formulations, testing protocols and analytical methods; and scientific and technological services, namely, scientific research, analysis, testing, and related scientific studies in the field of chemistry and molecular biology, namely, biologics and protein detection, characterization, analysis and testing; consulting services in the field of medical device product approval for commercial purposes

Filing History

TEAS SECTION 8 & 9 RECEIVED
Apr 28, 2026 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 28, 2026 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 27, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 27, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 27, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 27, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 27, 2025 COAR
WITHDRAWAL OF ATTORNEY GRANTED
Apr 21, 2025 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Apr 21, 2025 WOAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 18, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 18, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 18, 2023 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 16, 2023 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 28, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 28, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 22, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 21, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 3, 2017 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 3, 2017 AITU
USE AMENDMENT FILED
Jan 16, 2017 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 16, 2017 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 16, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 21, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jun 21, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 1, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
May 18, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 18, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
May 18, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 18, 2016 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 5, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jan 5, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jan 5, 2016 CNRT
ASSIGNED TO EXAMINER
Dec 22, 2015 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 16, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2015 NWOS
NEW APPLICATION ENTERED
Sep 14, 2015 NWAP